Rephonic
Artwork for Lung Cancer Update

Lung Cancer Update

Dr. Neil Love
Non-Small Cell Lung Cancer
Immunotherapy
Lung Cancer
Small Cell Lung Cancer
Chemotherapy
Pembrolizumab
EGFR
Targeted Therapy
Osimertinib
EGFR Mutations
Antibody-Drug Conjugates
Adjuvant Therapy
Clinical Trials
Neoadjuvant Chemotherapy
EGFR Mutation
Alk-Targeted Therapy
Adora Trial
Nivolumab
Pd-L1 Expression
Antibody Drug Conjugates

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.

PublishesMonthlyEpisodes359Founded20 years ago
Number of ListenersCategories
ScienceMedicineHealth & Fitness

Listen to this Podcast

Artwork for Lung Cancer Update

Latest Episodes

Dr Natalie Vokes from The University of Texas MD Anderson Cancer Center in Houston discusses recent developments with circulating tumor DNA assays in the management of lung cancer.

CME information and select publications here.

Dr Hossein Borghaei from Fox Chase Cancer Center in Philadelphia, Pennsylvania, and Dr Anne Chiang from Yale Cancer Center in New Haven, Connecticut, discuss key clinical trial data in the first-line management of ES-SCLC, real-world case studies and... more

Dr Luis Paz-Ares from the Spanish National Oncology Research Center in Madrid and Dr Shields from Indiana University School of Medicine in Indianapolis discuss key datasets surrounding first-line and maintenance therapy for patients with extensive-st... more

Dr Justin F Gainor, Dr Corey J Langer and Dr Misty Dawn Shields summarize the treatment landscape and review relevant clinical datasets for patients with lung cancer.

CME information and select publications here.

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Two Onc Docs
Two Onc DocsSam and Karine
Lung Cancer Rx
Lung Cancer RxOncology News Central

Recent Guests

Dr. Natalie Vokes
MD Anderson Cancer Center physician
MD Anderson Cancer Center
Episode: Lung Cancer — 5-Minute Journal Club with Dr Natalie Vokes: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
Hossein Borghaei
Medical oncologist; Fox Chase Cancer Center
Fox Chase Cancer Center
Episode: Extensive-Stage Small Cell Lung Cancer — Current Patterns of Care with First-Line and Maintenance Therapy
Anne Chiang
Medical oncologist; Yale Cancer Center
Yale Cancer Center
Episode: Extensive-Stage Small Cell Lung Cancer — Current Patterns of Care with First-Line and Maintenance Therapy
Aaron Lisberg
Medical Oncologist at the University of California, Los Angeles
University of California, Los Angeles
Episode: Lung Cancer — 5-Minute Journal Club Issue 4 with Dr Aaron Lisberg: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
Dr. Aaron Lisberg
Medical oncologist from the University of California, Los Angeles
University of California, Los Angeles
Episode: Lung Cancer — 5-Minute Journal Club Issue 3 with Dr Aaron Lisberg: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
Dr. Jacob Sands
Medical oncologist at Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Episode: Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 1 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
Ben Levy
Professor at Johns Hopkins Sidney Kimmel Cancer Center
Johns Hopkins Sidney Kimmel Cancer Center
Episode: Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
Dr. Justin Gainor
Medical Oncologist at Massachusetts General Hospital
Massachusetts General Hospital
Episode: First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor
Dr. Edward Garon
Professor, Director of the Rassica Oncology Program at UCLA
David Geffen School of Medicine
Episode: Cases from the Community: Integrating New Research Findings into Current Practice — Lung Cancer

Host

Dr. Neil Love
Host of the series; Medical Oncologist with a focus on thoracic oncology and ongoing clinical discussions.

Reviews

4.6 out of 5 stars from 47 ratings
  • Medicine resident subscriber

    Third year medicine resident applying to Heme onc fellowship. I am interested in lung cancer and this podcast inspires critical thinking about patient management and provokes thought about the lung cancer literature. Uniquely has fantastic interviews with experts in the field. A great listen. I recommend this to anyone interested in oncology and interested in improving their knowledge of lung cancer management.

    Apple Podcasts
    5
    MG2MD
    United States8 years ago
  • Heldere informatie over longkanker

    Hier ben ik heel blij mee.

    Ik wou dat zoiets in het Nederlands bestond.

    Apple Podcasts
    5
    Thea 1953
    Netherlands14 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Some listeners benefit from real-world perspectives on trial data and treatment sequencing.
Listeners praise expert interviews and practical clinical insights that help translate complex literature into patient care.
The show is seen as a reliable source for nuanced discussions on targeted therapies and biomarkers.

Top Science Podcasts

Radiolab
RadiolabWNYC Studios
Something You Should Know
Something You Should KnowMike Carruthers | OmniCast Media
Hidden Brain
Hidden BrainHidden Brain, Shankar Vedantam
StarTalk Radio
StarTalk RadioNeil deGrasse Tyson
Sasquatch Chronicles
Sasquatch ChroniclesSasquatch Chronicles - Bigfoot Encounters
Science Friday
Science FridayScience Friday and WNYC Studios
Are We Doomed?
Are We Doomed?NPR Network
Science Vs
Science VsSpotify Studios

Talking Points

Recent interactions between the hosts and their guests.

Lung Cancer — 5-Minute Journal Club with Dr Natalie Vokes: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
Q: What about the role of ctDNA after neoadjuvant therapy in guiding post-surgical decisions, such as continuation of immunotherapy or addition of other agents?
Post-neoadjuvant ctDNA positivity may identify patients who would benefit from continued or intensified therapy (e.g., immunotherapy) even if radiographic/pathologic responses look favorable, whereas ctDNA clearance often implies better outcomes and could support de-escalation in select cases.
Lung Cancer — 5-Minute Journal Club with Dr Natalie Vokes: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
Q: Could you think of a situation, again, with localized disease, a patient who doesn't have any driver mutations, where you would currently usually not offer adjuvant chemotherapy, but you would if the patient's CT DNA were positive?
If a patient has high-risk features after resection (e.g., extensive smoking history, high PD-L1, large tumor with lymphovascular invasion), a positive CT DNA result could push toward adjuvant therapy to maximize potential cure, since MRD positivity signals higher relapse risk and could tip the balance in favor of systemic treatment.
Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 2 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
Q: What are the key toxicities associated with Dato-DXD?
Key toxicities include mucositis, ocular surface toxicity, and interstitial lung disease, each requiring specific management strategies.
Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
Q: How do you make the decision between whether or not to start systemic therapy right away or do radiation therapy in SVC syndrome?
Dr. Levy discusses the importance of evaluating the patient's histology and typically consults with his radiation oncologist for swift radiation treatment, especially in cases of non-small cell lung cancer.
Small Cell Lung Cancer — Expert Perspectives on Actual Patient Cases
Q: How should we be managing Lambert-Eaton Syndrome?
Management should focus on treating the underlying cancer, ideally improving neurological function, though patients may have residual issues.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Lung Cancer Update

What is Lung Cancer Update about and what kind of topics does it cover?

A physician-led interview series that translates cutting-edge thoracic oncology research into practical insights for patient care. Conversations consistently cover tumor biology, targeted therapies, immunotherapy, and emerging diagnostic tools, with real-world clinical decision-making, trial data, and management of treatment-related toxicities highlighted across episodes. Notable strengths include deep clinical expertise from renowned oncologists, practical guidance for implementing new therapies, and a willingness to tackle complex, nuanced cases in NSCLC and SCLC. Listeners are likely clinicians seeking up-to-date treatment strategies and evidence-informed perspectives, as well as researchers looking for synthesis of trial data and transl... more

Where can I find podcast stats for Lung Cancer Update?

Rephonic provides a wide range of podcast stats for Lung Cancer Update. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Lung Cancer Update and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Lung Cancer Update get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Lung Cancer Update, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Lung Cancer Update?

Rephonic provides comprehensive predictive audience data for Lung Cancer Update, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Lung Cancer Update have?

To see how many followers or subscribers Lung Cancer Update has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Lung Cancer Update?

These podcasts share a similar audience with Lung Cancer Update:

1. Gastrointestinal Cancer Update
2. Two Onc Docs
3. Breast Cancer Update
4. Prostate Cancer Update
5. Lung Cancer Rx

How many episodes of Lung Cancer Update are there?

Lung Cancer Update launched 20 years ago and published 359 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Lung Cancer Update?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Lung Cancer Update?

Rephonic pulls ratings and reviews for Lung Cancer Update from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Lung Cancer Update?

Rephonic provides full transcripts for episodes of Lung Cancer Update. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Lung Cancer Update?

Recent guests on Lung Cancer Update include:

1. Dr. Natalie Vokes
2. Hossein Borghaei
3. Anne Chiang
4. Aaron Lisberg
5. Dr. Aaron Lisberg
6. Dr. Jacob Sands
7. Ben Levy
8. Dr. Justin Gainor

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days